Acerus Pharmaceuticals, Aytu deal

Acerus (formerly Trimel Pharmaceuticals Corp.) granted Aytu exclusive, U.S. marketing rights

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE